Leyden Labs is a biotech company that develops intranasal products for respiratory viruses, focusing on giving people the freedom to administer protection themselves.

Leyden Labs aims to help people live their lives to the fullest. Our platform targets commonalities of viral families to protect humanity from known and future viruses. Our portfolio of accessible intranasal product candidates may provide people with the freedom to immediately protect themselves from and prevent the spread of many variants of respiratory viruses, including ones in the influenza and coronavirus families.The Leyden Labs’ energetic team of world-renowned biotechnology veterans and fresh talent is dedicated to thinking differently to free humanity from the burden of respiratory viruses.

Google Ventures

F-Prime Capital

Casdin Capital

COM:LEYDENLABS

Leyden Labs

Analysis Not Available